Rare
lephants
Screener
Toggle theme
Scilex Holding Company
SCLXW
·
Healthcare, Drug Manufacturers - General, United States
Financial Statements
Profitability
Balance Sheet
Cash Flow
Share-Based Metrics
Valuation
Cash Flow History
Net Cash Flow Breakdown
Net Cash Flow
Cash Flow
›
Net Cash Flow Breakdown
Net Cash Flow Breakdown
Chart
Table
FY2025
FY2024
Total Cash from Operations:
$24.2M
Line Item
Value
% of Total
Other Financing
$5.5M
22.6%
Working Capital
$16.3M
67.4%
Other
$756.0K
3.1%
Net Cash Flow
$1.7M
7.0%
Download CSV
